Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.

The BeSt way of withdrawing biologic agents.

Allaart CF, Lems WF, Huizinga TW.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S14-8. Epub 2013 Oct 3.

PMID:
24129130
2.

Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study.

Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Breedveld FC, Dijkmans BA; FARR study group.

Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-77-82.

PMID:
17083767
3.

Rheumatoid arthritis patients with continued low disease activity have similar outcomes over 10 years, regardless of initial therapy.

Bergstra SA, Landewé RBM, Huizinga TWJ, Allaart CF.

Rheumatology (Oxford). 2017 Oct 1;56(10):1721-1728. doi: 10.1093/rheumatology/kex236.

PMID:
28957556
4.

Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study.

Allaart CF, Breedveld FC, Dijkmans BA.

J Rheumatol Suppl. 2007 Nov;80:25-33.

PMID:
17985420
5.

Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis.

van der Kooij SM, le Cessie S, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Zeben D, Kerstens PJ, Hazes JM, van Schaardenburg D, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jul;68(7):1153-8. doi: 10.1136/ard.2008.093294. Epub 2008 Oct 17.

PMID:
18930988
6.

The impact of four dynamic, goal-steered treatment strategies on the 5-year outcomes of rheumatoid arthritis patients in the BeSt study.

Klarenbeek NB, Güler-Yüksel M, van der Kooij SM, Han KH, Ronday HK, Kerstens PJ, Seys PE, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Jun;70(6):1039-46. doi: 10.1136/ard.2010.141234. Epub 2011 Mar 17.

PMID:
21415052
7.

Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.

van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, van Groenendael JH, Hazes JM, Breedveld FC, Allaart CF, Dijkmans BA.

Ann Rheum Dis. 2007 Oct;66(10):1356-62. Epub 2007 Feb 9.

8.

Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis.

van der Kooij SM, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Güler-Yüksel M, Zwinderman AH, Kerstens PJ, van der Lubbe PA, de Beus WM, Grillet BA, Ronday HK, Huizinga TW, Breedveld FC, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2009 Jun;68(6):914-21. doi: 10.1136/ard.2008.092254. Epub 2008 Jul 28.

PMID:
18662933
9.

Impact of biologic agents with and without concomitant methotrexate and at reduced doses in older rheumatoid arthritis patients.

Zhang J, Xie F, Delzell E, Yun H, Lewis JD, Haynes K, Chen L, Beukelman T, Saag KG, Curtis JR.

Arthritis Care Res (Hoboken). 2015 May;67(5):624-32. doi: 10.1002/acr.22510.

10.

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study.

van den Broek M, Klarenbeek NB, Dirven L, van Schaardenburg D, Hulsmans HM, Kerstens PJ, Huizinga TW, Dijkmans BA, Allaart CF.

Ann Rheum Dis. 2011 Aug;70(8):1389-94. doi: 10.1136/ard.2010.147751. Epub 2011 Apr 24.

PMID:
21515916
11.

Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.

Chang CY, Meyer RM, Reiff AO.

Arthritis Care Res (Hoboken). 2015 May;67(5):658-66. doi: 10.1002/acr.22477.

12.

Infliximab and methotrexate as induction therapy in patients with early rheumatoid arthritis.

van der Bijl AE, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Ten Wolde S, Han KH, van Krugten MV, Allaart CF, Breedveld FC, Dijkmans BA.

Arthritis Rheum. 2007 Jul;56(7):2129-34.

13.

Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.

Ferraccioli GF, Assaloni R, Di Poi E, Gremese E, De Marchi G, Fabris M.

Rheumatology (Oxford). 2002 Oct;41(10):1109-12.

PMID:
12364628
14.

Discontinuation of biologics in patients with rheumatoid arthritis.

Tanaka Y, Hirata S, Saleem B, Emery P.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4 Suppl 78):S22-7. Epub 2013 Oct 3. Review.

PMID:
24129132
15.

Two-year results of disease activity score (DAS)-remission-steered treatment strategies aiming at drug-free remission in early arthritis patients (the IMPROVED-study).

Heimans L, Akdemir G, Boer KV, Goekoop-Ruiterman YP, Molenaar ET, van Groenendael JH, Peeters AJ, Steup-Beekman GM, Lard LR, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Arthritis Res Ther. 2016 Jan 21;18:23. doi: 10.1186/s13075-015-0912-y.

16.

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study).

Nam JL, Villeneuve E, Hensor EM, Conaghan PG, Keen HI, Buch MH, Gough AK, Green MJ, Helliwell PS, Keenan AM, Morgan AW, Quinn M, Reece R, van der Heijde DM, Wakefield RJ, Emery P.

Ann Rheum Dis. 2014 Jan;73(1):75-85. doi: 10.1136/annrheumdis-2013-203440. Epub 2013 Aug 2.

PMID:
23912798
17.

Twelve-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis: Real-Life Data From a Local Registry.

Favalli EG, Pregnolato F, Biggioggero M, Becciolini A, Penatti AE, Marchesoni A, Meroni PL.

Arthritis Care Res (Hoboken). 2016 Apr;68(4):432-9. doi: 10.1002/acr.22788.

18.

A two-step treatment strategy trial in patients with early arthritis aimed at achieving remission: the IMPROVED study.

Heimans L, Wevers-de Boer KV, Visser K, Goekoop RJ, van Oosterhout M, Harbers JB, Bijkerk C, Speyer I, de Buck MP, de Sonnaville PB, Grillet BA, Huizinga TW, Allaart CF.

Ann Rheum Dis. 2014 Jul;73(7):1356-61. doi: 10.1136/annrheumdis-2013-203243. Epub 2013 May 28.

PMID:
23716067
19.

Discontinuation of infliximab in rheumatoid arthritis patients in clinical remission.

Nawata M, Saito K, Nakayamada S, Tanaka Y.

Mod Rheumatol. 2008;18(5):460-4. doi: 10.1007/s10165-008-0089-1. Epub 2008 Jun 6.

PMID:
18535759
20.

BeSt practice: the success of early-targeted treatment in rheumatoid arthritis.

van den Broek M, Lems WF, Allaart CF.

Clin Exp Rheumatol. 2012 Jul-Aug;30(4 Suppl 73):S35-8. Epub 2012 Oct 18.

PMID:
23078756

Supplemental Content

Support Center